Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review

被引:54
|
作者
Wen Jinhua [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Pharm, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
absorption; distribution; elimination; pharmacokinetics; ursolic acid; POLOXAMER; 407; LIPOSOMES; EFFICACY; ENHANCE;
D O I
10.1002/ardp.201800222
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ursolic acid (UA) is a natural triterpene compound found in various fruits and vegetables. UA has a widespread pharmacologic effect, including antitumor, anti-inflammatory, anti-oxidant, anti-apoptotic, anti-allergy, and anti-carcinogenic effects. UA can be used as an alternative medicine for the treatment and prevention of many diseases. However, the bioavailability of UA by oral administration is low since it is absorbed by the intestine through passive diffusion. Therefore, some novel technologies are used to produce UA preparations that can change the pharmacokinetics process and increase its solubility and bioavailability. At present, pharmacokinetic studies on UA are few. In this paper, we will review the pharmacokinetics features of free UA and some novel UA preparations in vitro and in vivo, in order to provide a reference for rational utilization and drug design of UA.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] The pharmacology, pharmacokinetics, and toxicity of spinosin: A mini review
    Kuang, Xiaolan
    She, Ganshu
    Ma, Ting
    Cai, Wanna
    Zhao, Jingjing
    Liu, Bo
    Xu, Fangfang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Clinical pharmacokinetics and interaction of centchroman - A mini review
    Lal, Jawahar
    CONTRACEPTION, 2010, 81 (04) : 275 - 280
  • [43] Effects of ursolic acid on different steps of the angiogenic process
    Cárdenas, C
    Quesada, AR
    Medina, MA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (02) : 402 - 408
  • [44] Recent Advances in Carbon Dots for In Vitro/Vivo Fluorescent Bioimaging: A Mini-Review
    He, Chen
    Lin, Xiaofeng
    Mei, Yanqiu
    Luo, Yan
    Yang, Min
    Kuang, Ying
    Yi, Xiaoqing
    Zeng, Weijia
    Huang, Qitong
    Zhong, Bin
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [45] Discovery of ursolic acid prodrug (NX-201): Pharmacokinetics and in vivo antitumor effects in PANC-1 pancreatic cancer
    Yoon, Yeohong
    Lim, Jee Woong
    Kim, Jiyoung
    Kim, Younggi
    Chun, Keun Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (22) : 5524 - 5527
  • [46] Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization
    Alvarado, H. L.
    Abrego, G.
    Souto, E. B.
    Garduno-Ramirez, M. L.
    Clares, B.
    Garcia, M. L.
    Calpena, A. C.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 130 : 40 - 47
  • [47] Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans
    Wen-Jing Wang
    Chan-Chan Liu
    Yan-Tong Li
    Miao-Qian Li
    Yu-Ting Fu
    Xin-Chen Li
    Wei-Dong Jie-Kang
    Current Microbiology, 2022, 79
  • [48] Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model
    Sun, Qiang
    He, Man
    Zhang, Meng
    Zeng, Sha
    Chen, Li
    Zhou, Lijuan
    Xu, Haibo
    FITOTERAPIA, 2020, 147
  • [49] Assessment of ursolic acid effect on in vitro model of cardiac fibrosis
    Hosseiny, Samane Sadat
    Esmaeili, Zahra
    Neshati, Zeinab
    TOXICOLOGY IN VITRO, 2024, 101
  • [50] Phase II metabolites of mycophenolic acid:: In vitro/in vivo characterization and pharmacokinetics in renal transplants
    Picard, N
    Prémaud, A
    Rousseau, A
    Le Meur, Y
    Ratanasavangh, D
    Marquet, P
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 538 - 538